Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis.

Patients with endoscopic esophagitis had significantly more frequently EUSTAR reported esophageal symptoms (“reflux and/or dysphagia”) and slightly higher mRSS scores, while the distribution of individual upper gastrointestinal tract symptoms (heartburn, dysphagia, and regurgitation), as well as that of the UCLA GIT 2.0 score and subscales, did not reach statistical significance (Table 5 ).

also in 111,027 other papers